463 related articles for article (PubMed ID: 315561)
1. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
Kao KJ; Pizzo SV; McKee PA
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
[TBL] [Abstract][Full Text] [Related]
2. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
[TBL] [Abstract][Full Text] [Related]
3. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
[TBL] [Abstract][Full Text] [Related]
4. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
5. Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.
Kao KJ; Pizzo SV; McKee PA
J Clin Invest; 1979 Apr; 63(4):656-64. PubMed ID: 108291
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
7. Effect of carbohydrate modifications of factor VIII/von Willebrand factor on binding to platelets.
Goudemand J; Mazurier C; Samor B; Bouquelet S; Montreuil J; Goudemand M
Thromb Haemost; 1985 Jun; 53(3):390-5. PubMed ID: 2864750
[TBL] [Abstract][Full Text] [Related]
8. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen.
Sixma JJ; Sakariassen KS; Stel HV; Houdijk WP; In der Maur DW; Hamer RJ; de Groot PG; van Mourik JA
J Clin Invest; 1984 Sep; 74(3):736-44. PubMed ID: 6332119
[TBL] [Abstract][Full Text] [Related]
9. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
Levine SP; Moake JL
Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
[TBL] [Abstract][Full Text] [Related]
10. Comparison of thrombin and ristocetin in the interaction between von Willebrand factor and platelets.
Harrison RL; McKee PA
Blood; 1983 Aug; 62(2):346-53. PubMed ID: 6307433
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand factor in the vessel wall mediates platelet adherence.
Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
[TBL] [Abstract][Full Text] [Related]
12. Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition.
Sixma JJ; Sakariassen KS; Beeser-Visser NH; Ottenhof-Rovers M; Bolhuis PA
Blood; 1984 Jan; 63(1):128-39. PubMed ID: 6418228
[TBL] [Abstract][Full Text] [Related]
13. The agglutination of human platelets by botrocetin: evidence that botrocetin and ristocetin act at different sites on the factor VIII molecule and platelet membrane.
Howard MA; Perkin J; Salem HH; Firkin BG
Br J Haematol; 1984 May; 57(1):25-35. PubMed ID: 6426499
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor. A protein which binds at the cell surface interface between platelets.
Senogles SE; Nelsestuen GL
J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342
[TBL] [Abstract][Full Text] [Related]
15. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
16. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
17. Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand syndrome: an assay for von Willebrand factor binding by antibody.
Fricke WA; Brinkhous KM; Garris JB; Roberts HR
Blood; 1985 Sep; 66(3):562-9. PubMed ID: 3927998
[TBL] [Abstract][Full Text] [Related]
18. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
[TBL] [Abstract][Full Text] [Related]
19. Platelet-binding of the von Willebrand factor.
Green D; Muller HP
Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity.
Kao KJ; Tsai BS; McKee PA; Lefkowitz RJ; Pizzo SV
Thromb Res; 1983 May; 30(3):301-8. PubMed ID: 6408756
[No Abstract] [Full Text] [Related]
[Next] [New Search]